These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 30414957)
1. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy. Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957 [TBL] [Abstract][Full Text] [Related]
2. [Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy]. Ojea Calvo A; Núñez López A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Gómez-González MC; González Piñeiro A; Otero García M; Nogueira March JL Actas Urol Esp; 2003 Jun; 27(6):428-37. PubMed ID: 12918149 [TBL] [Abstract][Full Text] [Related]
3. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. Egan AJ; Bostwick DG Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194 [TBL] [Abstract][Full Text] [Related]
4. Perineural invasion on prostate biopsy does not predict adverse pathological outcome. Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294 [TBL] [Abstract][Full Text] [Related]
5. Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy. Fleshner K; Assel M; Benfante N; Lee J; Vickers A; Fine S; Carlsson S; Eastham J J Urol; 2016 Sep; 196(3):703-8. PubMed ID: 27049874 [TBL] [Abstract][Full Text] [Related]
6. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group. Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ; J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519 [TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis. Ellis CL; Partin AW; Han M; Epstein JI J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307 [TBL] [Abstract][Full Text] [Related]
8. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance. Godtman RA; Schafferer M; Pihl CG; Stranne J; Hugosson J J Urol; 2018 Oct; 200(4):779-785. PubMed ID: 29730198 [TBL] [Abstract][Full Text] [Related]
10. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Wheeler TM; Dillioglugil O; Kattan MW; Arakawa A; Soh S; Suyama K; Ohori M; Scardino PT Hum Pathol; 1998 Aug; 29(8):856-62. PubMed ID: 9712429 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods. Iremashvili V; Lokeshwar SD; Jorda M; Pelaez L; Soloway MS J Urol; 2013 Jul; 190(1):84-90. PubMed ID: 23246479 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714 [TBL] [Abstract][Full Text] [Related]
14. Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy. Ristau BT; Tomaszewski JJ; Chen YF; Bertolet M; Woldemichael E; Nelson JB World J Urol; 2015 Sep; 33(9):1269-74. PubMed ID: 25366883 [TBL] [Abstract][Full Text] [Related]
15. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors. Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158 [TBL] [Abstract][Full Text] [Related]
16. Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer. Okihara K; Kamoi K; Lane RB; Evans RB; Troncoso P; Babaian RJ J Clin Ultrasound; 2002; 30(3):123-31. PubMed ID: 11948567 [TBL] [Abstract][Full Text] [Related]
17. Prostate cancer polar localization on core biopsy predicts pathologic stage. Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850 [TBL] [Abstract][Full Text] [Related]
18. The significance of a positive bladder neck margin after radical prostatectomy: the American Joint Committee on Cancer Pathological Stage T4 designation is not warranted. Pierorazio PM; Epstein JI; Humphreys E; Han M; Walsh PC; Partin AW J Urol; 2010 Jan; 183(1):151-7. PubMed ID: 19914651 [TBL] [Abstract][Full Text] [Related]
19. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors]. Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198 [TBL] [Abstract][Full Text] [Related]
20. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy. Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]